- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05068297
The Impact of Germanium-Embedded Knee Brace on Patient Recovery After ACL Reconstruction
The Impact of Germanium-Embedded Knee Brace on Patient Recovery After ACL Reconstruction: a Blinded and Randomized Controlled Trial
Anti-inflammatory brace technology has demonstrated superior clinical outcomes in the management of knee osteoarthritis and accelerate recovery time for Major League Soccer players. Authors have postulated that embedding germanium into cotton garments increases circulation and augments the inflammatory process through a transdermal micro-electromagnetic field. In addition to immunomodulatory effects, knee braces immobilize and stabilize the joint through tactile feedback from the skin. Thus, a germanium-embedded knee brace may provide inflammatory control to augment pain and edema while concomitantly enhancing proprioception. ACL Reconstruction rehabilitation goals during the acute post-operative phase include diminishment of pain and edema as well as restoration of knee range-of-motion. The presented study intends to assess the impact of a germanium-embedded knee brace on patient recovery after ACL reconstruction.
Single-center blinded randomized controlled clinical trial to study effectiveness of germanium-infused knee brace on rehabilitation in patient population undergoing ACL reconstruction. Patients will be randomized into germanium-infused knee brace group and compared to a replica knee brace group. Inclusion criteria will include skeletally mature individuals undergoing primary ACL reconstruction. Exclusion criteria will include autoimmune disorders and history of surgery on ipsilateral joint. The presented protocol intends to assess the impact of a germanium-embedded knee brace on patient recovery after ACL reconstruction. The primary outcome measure was chosen for its implications for the design and conduct of the study,1 including well-validated outcome instrument for comparison, facilitation of a priori power analysis, randomization, and blinding. Secondary outcomes were chosen for their pertinence to surgeon decision-making during patient rehabilitation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18-100 years old
- Male or female
- Compliant patient
- BMI less than 35
- Undergoing ACL reconstruction within 30 days
Exclusion Criteria:
- Rheumatoid Arthritis
- Poorly controlled diabetes (HgA1c > 7.5)
- Previous blood clots
- BMI greater than 35
- Varicosities on operative leg
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Germanium-Embedded Knee Brace
Following surgery the patients effected limb would be placed in an Germanium-Embedded Knee Brace
|
Germanium-Embedded Knee Brace will be applied to the effected limb following ACL reconstruction
|
|
Active Comparator: Replica Knee Brace
Following surgery the patients effected limb would be placed in a replica knee brace
|
Replica Knee brace will be applied to the effected limb following ACL reconstruction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short Form 36 (SF-36)
Time Frame: 4 weeks
|
A well-validated patient reported outcome and the most commonly used outcome instrument in orthopaedics.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Estimation
Time Frame: 6 weeks
|
Visual Analog Scale
|
6 weeks
|
|
Leg Circumference
Time Frame: 6 weeks
|
In centimeters, measure by senior surgeon during physical exam using a tape measure at standard post-operative visits
|
6 weeks
|
|
Knee Range of Motion
Time Frame: 6 weeks
|
In degrees, measured by a senior surgeon using a Goniometer, at standard post-operative visits
|
6 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IW001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anterior Cruciate Ligament Injuries
-
Alexander Rofner-MorettiRecruitingAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Reconstruction | Anterior Cruciate Ligament InjuryAustria
-
Haute Ecole ARC SanteCompletedAnterior Cruciate Ligament Injury | Anterior Cruciate Ligament Reconstruction RehabilitationSwitzerland
-
Medical University of GrazCompletedAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Injury | Knee Instability | Anterior Cruciate Ligament Graft FailureAustria
-
Universidad de GranadaRecruitingAnterior Cruciate Ligament Injury | Anterior Cruciate Ligament (ACL) ReconstructionSpain
-
University of BathVersus ArthritisRecruitingPost-traumatic Osteoarthritis | Anterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Tear | Anterior Cruciate Ligament ReconstructionUnited Kingdom
-
Ankara City Hospital BilkentRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearTurkey
-
Sanford HealthActive, not recruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearUnited States
-
University of Colorado, DenverChildren's Hospital ColoradoActive, not recruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearUnited States
-
eMKa MED Medical CenterWroclaw Medical UniversityRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Tear | Knee Injuries | Knee Ligament InjuryPoland
-
University of CalgaryWorkers' Compensation Board, AlbertaCompletedAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Injury | Chronic Instability of Knee | Deficiency of Anterior Cruciate LigamentCanada
Clinical Trials on Incrediwear Germanium-Embedded Knee Brace following ACL reconstruction
-
Total Sports Medicine & OrthopedicsIncrediwear Holdings IncNot yet recruitingKnee Arthroscopy | Knee Arthropathy Associated With Other Conditions